Scott Brown joined TRACON as Director, Finance and Controller in August 2015, was promoted to Sr. Director, Finance and Controller in January 2017, and was promoted to Vice President, Finance and Head of Finance in January 2019, and CFO in January 2021. Prior to joining TRACON, Mr. Brown was Associate Director, Finance at Ardea Biosciences (acquired by AstraZeneca) where he led finance and accounting for Ardea Biosciences as a subsidiary of AstraZeneca from 2013 to 2015. Before that, Mr. Brown held positions of increasing responsibility in finance and accounting at SciClone Pharmaceuticals, Inc., Exelixis, Inc., AcelRx, Inc., Spinal Elements, Inc., Stewart Title, and as an auditor for KPMG, LLP. Mr. Brown received a B.S. from the University of California, Santa Barbara, a M.S. in Accountancy from San Diego State University, and is a Certified Public Accountant licensed in the state of California.